Schisandrin B
Schisandrin B has been studied in 2 papers since 2023: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Oct 17, 2025: “Schisandrin B combined with vitamin D inhibits NLRP3 inflammasome to improve cognitive dysfunction and Alzheimer's disease”.
See all 2 papers on schisandrin B
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National College Students Innovation and Entrepreneurship Training Program and 1 more
- Animals2
What did studies of schisandrin B find?
4Studies of schisandrin B measured 4 outcomes, among them senescence-associated beta-galactosidase, cellular senescence and hepatic collagen deposition.
Senescence-associated beta-galactosidase
upin human cells1
1 study
Senescence-associated beta-galactosidase
upin human cells1
Schisandrin B increases senescence-associated beta-galactosidase in human cells.
Cells20 μM24 h
Cellular senescence
upin mice1
1 study
Cellular senescence
upin mice1
Schisandrin B induces cellular senescence in mice.
Animals40 mg/kg30 d
Hepatic collagen deposition
downin mice1
1 study
Hepatic collagen deposition
downin mice1
Schisandrin B decreases hepatic collagen deposition in mice.
Animals40 mg/kg30 d
AST
downin mice1
1 study
AST
downin mice1
Schisandrin B decreases AST in mice (AST -53.2%, ALT -63.6%).
Animals40 mg/kg30 d